Evidence map›Paper›PMID 39747932›Full record

ArticleScientific reports2025

Imply on diagnosis and early prognosis of preoperative [

K Pełka, K Koczyk, L Koperski, T Dziedzic, A Nowak, L Królicki, P Kunert, J Kunikowska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Head-to-head comparison ofBrazilian journal of otorhinolaryngology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

K PełkaNuclear Medicine Department, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland. kacper.pelka@wum.edu.pl.
K KoczykDepartment of Neurosurgery, Medical University of Warsaw, Warsaw, Poland.
L KoperskiDepartment of Pathology, Medical University of Warsaw, Warsaw, Poland.
T DziedzicDepartment of Neurosurgery, Medical University of Warsaw, Warsaw, Poland.
A NowakDepartment of Neurosurgery, Medical University of Warsaw, Warsaw, Poland.
L KrólickiNuclear Medicine Department, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland.
P KunertDepartment of Neurosurgery, Medical University of Warsaw, Warsaw, Poland.
J KunikowskaNuclear Medicine Department, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PET/CT targeting prostate-specific membrane antigen (PSMA) is commonly used in patients with prostate cancer. PSMA has been found in other solid tumours, including primary brain tumours. The aim of this study was to evaluate the usefulness of [

Indexed as

Brain NeoplasmsGallium IsotopesGallium RadioisotopesPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overEdetic AcidFemaleGlioblastomaGliomaHumansMaleMiddle AgedOligopeptidesPrognosisEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesPSMA-11Radiopharmaceuticals[68Ga]Ga-PSMA-11GBM; primary glial tumourGlioblastomaPSMA PET/CT

Identifiers

PMID39747932
PMCPMC11697079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.